An In-depth Review on Argemone mexicana in the Management of Liver Health and Liver Cancer


Цитировать

Полный текст

Аннотация

Introduction:Argemone mexicana, commonly known as the Mexican prickly poppy, has been historically employed in traditional medicine for various ailments, including liver disorders. Given the rising prevalence of liver diseases, including cancer, investigating the potential efficacy of Argemone mexicana in promoting liver health is of paramount importance. This review aims to provide a comprehensive analysis of the existing literature on the hepatoprotective and anticancer properties of Argemone mexicana.

Methodology:A systematic literature search was conducted across PubMed, Google Scholar, and relevant botanical and pharmacological databases. Studies from various sources, including in vitro experiments, animal models, and clinical trials, were included in the review. The search focused on articles published up to 2010-2023, encompassing research that explored the botanical characteristics, chemical composition, traditional uses, and pharmacological properties of Argemone mexicana, specifically emphasizing its impact on liver health and cancer.

Results:The review revealed a wealth of studies highlighting the diverse pharmacological properties of Argemone mexicana. The botanical composition includes compounds with antioxidant and anti-inflammatory potential, suggesting hepatoprotective effects. Studies using in vitro and in vivo models demonstrated promising outcomes regarding liver function improvement and inhibition of liver cancer cell proliferation. While some clinical studies supported the traditional uses of Argemone mexicana, further well-designed trials are warranted to establish its clinical efficacy.

Conclusion:In conclusion, Argemone mexicana shows promise as a natural agent for promoting liver health and combating liver cancer. Bioactive compounds with antioxidant and anti-inflammatory properties suggest potential hepatoprotective effects. However, translating these findings into clinical practice requires further rigorous investigation, including well-designed clinical trials. This review provides a foundation for future research efforts aimed at elucidating the full therapeutic potential of Argemone mexicana in liver health and cancer management.

Об авторах

Istuti Saraswat

Department of Biotechnology, GLA University

Email: info@benthamscience.net

Anjana Goel

Department of Biotechnology, GLA University

Автор, ответственный за переписку.
Email: info@benthamscience.net

Jyoti Gupta

Department of Biotechnology, GLA University

Email: info@benthamscience.net

Список литературы

  1. Najmi, A.; Javed, S.A.; Al Bratty, M.; Alhazmi, H.A. Modern approaches in the discovery and development of plant-based natural products and their analogs as potential therapeutic agents. Molecules, 2022, 27(2), 349. doi: 10.3390/molecules27020349 PMID: 35056662
  2. Li, X.; Sun, R.; Liu, R. Natural products in licorice for the therapy of liver diseases: Progress and future opportunities. Pharmacol. Res., 2019, 144, 210-226. doi: 10.1016/j.phrs.2019.04.025 PMID: 31022523
  3. Daliu, P.; Santini, A.; Novellino, E. A decade of nutraceutical patents: where are we now in 2018? Expert Opin. Ther. Pat., 2018, 28(12), 875-882. doi: 10.1080/13543776.2018.1552260 PMID: 30484340
  4. Pathak, R.; Goel, A.; Tripathi, S.C. Medicinal property and ethnopharmacological activities of Argemone mexicana: an overview. Ann. Rom. Soc. Cell Biol., 2021, 2021, 1615-1641.
  5. Plazas, E.; Avila M, M.C.; Muñoz, D.R.; Cuca S, L.E. Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases. Pharmacol. Res., 2022, 177, 106126. doi: 10.1016/j.phrs.2022.106126 PMID: 35151857
  6. Brahmachari, G.; Gorai, D.; Roy, R. Argemone mexicana: Chemical and pharmacological aspects. Rev. Bras. Farmacogn., 2013, 23(3), 559-575. doi: 10.1590/S0102-695X2013005000021
  7. Priya, C.L.; Rao, K.V. Ethanobotanical and current ethanopharmacological aspects of Argemone mexicana Linn: an overview. Int. J. Pharm. Sci. Res., 2012, 3(7), 2143.
  8. Bhattacharjee, I.; Chatterjee, S.K.; Chatterjee, S.; Chandra, G. Antibacterial potentiality of Argemone mexicana solvent extracts against some pathogenic bacteria. Mem. Inst. Oswaldo Cruz, 2006, 101(6), 645-648. doi: 10.1590/S0074-02762006000600011 PMID: 17072477
  9. Dutta, S.; Hazra, K.; Paria, D.; Ghosal, S.; Dixit, A.K.; Rao, M.M. Phyto pharmacognostical Evaluation of Argemone mexicana L. Seeds. J. Pharmacogn. Phytochem., 2018, 7(6), 1507-1513.
  10. Loza-Müller, L.J.A.; Laines-Hidalgo, J.I.; Monforte-González, M.; Vázquez-Flota, F. Alkaloid distribution in seeds of Argemone mexicana L.(Papaveraceae). J. Mex. Chem. Soc., 2021, 65(4), 501-506. doi: 10.29356/jmcs.v65i4.1574
  11. Singh, S.K.; Pandey, V.D.; Singh, A.; Singh, C. Antibacterial activity of seed extracts of Argemone mexicana L. on some pathogenic bacterial strains. Afr. J. Biotechnol., 2009, 8(24), 7077-7081.
  12. Martínez-Delgado, A.A.; Anda, J.; León-Morales, J.M.; Mateos-Díaz, J.C.; Gutiérrez-Mora, A.; Castañeda-Nava, J.J. Argemone species: Potential source of biofuel and high-value biological active compounds. Environ. Eng. Res., 2022, 27(2), 200619. doi: 10.4491/eer.2020.619
  13. Ibrahim, H.A.; Umar, M.A.; Bello, B.A.; Aliyu, A.; Ahmad, A. Analgesic and anti-inflammatory studies on the roots Argemone mexicana Linn (Family: Papaveraceae). J Pharm Biol Sci, 2016, 11(3), 92-95.
  14. Gbesso, G.H.F.; Gbesso, F.K.; Adoukonou, R.C.F.; Akabassi, G.C.; Padonou, E.A.; Brice, A.; Tente, H. Traditional knowledge and uses of Argemone mexicana L. (Papaveraceae) in southern Benin. Ethnobot. Res. Appl., 2021, 21, 1-1. doi: 10.32859/era.21.20.1-11
  15. Saran, S.; Padalia, H.; Ganeshaiah, K.N.; Oberai, K.; Singh, P.; Jha, A.K.; Shiva, R.K.; Verma, P.A.; Uniyal, S.; Senthil, K.A. Indian Bioresource Information Network (IBIN). In: Remote Sensing of Northwest Himalayan Ecosystems; Springer, 2019; pp. 251-264.
  16. Nancy, A.; Praveena, A. Argemone mexicana : A boon to medicinal and pharmacological approaches in current scenario. Cardiovascul.Hematol. Agent Med. Chem., 2017, 15(2), 78-90.
  17. Kranti, W.; Nivedita, G.; Mahesh, S.; Jadhav, R. Efficiency of phytochemicals obtained from selected invasive weeds against mustard aphid (Lipaphis Erysimi) Kalt. Res. Jr. Agril Sci., 2023, 14(1), 242-246.
  18. Conway, S. Anatomy and Morphology of the Seed Coat in the Texas Species of Argemone. PhD Thesis, Texas State University, San Marcos, Texas, 2022.
  19. Abubakar, A.; Dafam, D.G.; Yakubu, T.P.; Sanogo, R.; Diallo, D.; Alemika, T. Pharmacognostic, physicochemical and phytochemical investigations on aerial parts of Argemone mexicana L. Res. J.Pharmacog, 2020, 7(3), 15-24.
  20. Osho, A.; Adetunji, T. Antimicrobial activity of the essential oil of Argemone mexicana Linn. J. Med. Plants Res., 2010, 4(1), 19-22.
  21. Apu, A.S.; Al-Baizyd, A.H.; Ara, F.; Bhuyan, S.H.; Matin, M.; Hossain, M.F. Phytochemical analysis and bioactivities of Argemone mexicana Linn. leaves. Pharmacologyonline, 2012, 3, 16-23.
  22. Jaiswal, J.; Siddiqi, N.J.; Fatima, S.; Abudawood, M.; AlDaihan, S.K.; Alharbi, M.G.; de Lourdes Pereira, M.; Sharma, P.; Sharma, B. Analysis of biochemical and antimicrobial properties of bioactive molecules of Argemone mexicana. Molecules, 2023, 28(11), 4428. doi: 10.3390/molecules28114428 PMID: 37298904
  23. Chaity, F.R.; Rashid, M.A.; Rahman, M.S. Biological investigations of the whole plant of Argemone mexicana (L.). dhaka university. J. Pharm. Sci., 2021, 20(1), 135-138.
  24. Lingaraju, D.P.; Sudarshana, M.S.; Mahendra, C.; Rao, K.P. Phytochemical screening and antimicrobial activity of leaf extracts of Eryngium foetidum L. (Apiaceae). Indo Am. J. Pharmaceut. Res., 2016, 6(2), 4339-4344.
  25. Ali, S.A.; Sharief, N.H.; Mohamed, Y.S. Hepatoprotective activity of some medicinal plants in Sudan. Evid. Based Complement. Alternat. Med., 2019, 2019, 1-16. doi: 10.1155/2019/2196315 PMID: 31929810
  26. Warikoo, R.; Kumar, S. Impact of Argemone mexicana extracts on the cidal, morphological, and behavioral response of dengue vector, Aedes aegypti L. (Diptera: Culicidae). Parasitol. Res., 2013, 112(10), 3477-3484. doi: 10.1007/s00436-013-3528-7 PMID: 23835923
  27. Khan, A.M.; Bhadauria, S. Analysis of medicinally important phytocompounds from Argemone mexicana. J. King Saud Univ. Sci., 2019, 31(4), 1020-1026. doi: 10.1016/j.jksus.2018.05.009
  28. Gelband, H.; Chen, C.J.; Chen, W.; Franceschi, S.; Hall, S.A.; London, W.T.; McGlynn, K.A. Liver Cancer In: Cancer: Disease Control Priorities; he International Bank for Reconstruction and Development / The World Bank: Washington (DC), 2016.
  29. Sia, D.; Villanueva, A.; Friedman, S.L.; Llovet, J.M. Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology, 2017, 152(4), 745-761. doi: 10.1053/j.gastro.2016.11.048 PMID: 28043904
  30. Anwanwan, D.; Singh, S.K.; Singh, S.; Saikam, V.; Singh, R. Challenges in liver cancer and possible treatment approaches. Biochimica et Biophysica Acta (BBA)-. Rev. Can., 2020, 1873(1), 188314.
  31. Reyna-Margarita, H.R.; Irais, C.M.; Mario-Alberto, R.G.; Agustina, R.M.; Luis-Benjamín, S.G.; David, P.E. Plant phenolics and lectins as vaccine adjuvants. Curr. Pharm. Biotechnol., 2019, 20(15), 1236-1243. doi: 10.2174/1389201020666190716110705 PMID: 31333121
  32. Liu, C.Y.; Chen, K.F.; Chen, P.J. Treatment of liver cancer. Cold Spring Harb. Perspect. Med., 2015, 5(9), a021535. doi: 10.1101/cshperspect.a021535 PMID: 26187874
  33. Alqahtani, A.; Khan, Z.; Alloghbi, A.; Said Ahmed, T.S.; Ashraf, M.; Hammouda, D.M. Hepatocellular carcinoma: molecular mechanisms and targeted therapies. Medicina (Kaunas), 2019, 55(9), 526. doi: 10.3390/medicina55090526 PMID: 31450841
  34. Blachier, M.; Leleu, H.; Peck-Radosavljevic, M.; Valla, D.C.; Roudot-Thoraval, F. The burden of liver disease in Europe: A review of available epidemiological data. J. Hepatol., 2013, 58(3), 593-608. doi: 10.1016/j.jhep.2012.12.005 PMID: 23419824
  35. Rahib, L.; Smith, B.D.; Aizenberg, R.; Rosenzweig, A.B.; Fleshman, J.M.; Matrisian, L.M. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res., 2014, 74(11), 2913-2921. doi: 10.1158/0008-5472.CAN-14-0155 PMID: 24840647
  36. Terrault, N.A.; Lok, A.S.F.; McMahon, B.J.; Chang, K.M.; Hwang, J.P.; Jonas, M.M.; Brown, R.S., Jr; Bzowej, N.H.; Wong, J.B. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology, 2018, 67(4), 1560-1599. doi: 10.1002/hep.29800 PMID: 29405329
  37. Johnson, P.J.; Berhane, S.; Kagebayashi, C.; Satomura, S.; Teng, M.; Reeves, H.L.; O’Beirne, J.; Fox, R.; Skowronska, A.; Palmer, D.; Yeo, W.; Mo, F.; Lai, P.; Iñarrairaegui, M.; Chan, S.L.; Sangro, B.; Miksad, R.; Tada, T.; Kumada, T.; Toyoda, H. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J. Clin. Oncol., 2015, 33(6), 550-558. doi: 10.1200/JCO.2014.57.9151 PMID: 25512453
  38. Sun, E.J.; Wankell, M.; Palamuthusingam, P.; McFarlane, C.; Hebbard, L. Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Biomedicines, 2021, 9(11), 1639. doi: 10.3390/biomedicines9111639 PMID: 34829868
  39. Mintz, K.J.; Leblanc, R.M. The use of nanotechnology to combat liver cancer: Progress and perspectives. Biochim. Biophys. Acta Rev. Cancer, 2021, 1876(2), 188621. doi: 10.1016/j.bbcan.2021.188621 PMID: 34454983
  40. Wang, H.; Lin, D.; Yu, Q.; Li, Z.; Lenahan, C.; Dong, Y.; Wei, Q.; Shao, A. A promising future of ferroptosis in tumor therapy. Front. Cell Dev. Biol., 2021, 9, 629150. doi: 10.3389/fcell.2021.629150 PMID: 34178977
  41. Saraswat, V.A.; Pandey, G.; Shetty, S. Treatment algorithms for managing hepatocellular carcinoma. J. Clin. Exp. Hepatol., 2014, 4(Suppl. 3), S80-S89. doi: 10.1016/j.jceh.2014.05.004 PMID: 25755616
  42. Charrière, B.; Maulat, C.; Suc, B.; Muscari, F. Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma. World J. Hepatol., 2016, 8(21), 881-890. doi: 10.4254/wjh.v8.i21.881 PMID: 27478538
  43. Allaire, M.; Goumard, C.; Lim, C.; Le Cleach, A.; Wagner, M.; Scatton, O. New frontiers in liver resection for hepatocellular carcinoma. JHEP Reports, 2020, 2(4), 100134. doi: 10.1016/j.jhepr.2020.100134 PMID: 32695968
  44. Grandhi, M.S.; Kim, A.K.; Ronnekleiv-Kelly, S.M.; Kamel, I.R.; Ghasebeh, M.A.; Pawlik, T.M. Hepatocellular carcinoma: From diagnosis to treatment. Surg. Oncol., 2016, 25(2), 74-85. doi: 10.1016/j.suronc.2016.03.002 PMID: 27312032
  45. Liu, C.; Yang, M.; Zhang, D.; Chen, M.; Zhu, D. Clinical cancer immunotherapy: Current progress and prospects. Front. Immunol., 2022, 13, 961805. doi: 10.3389/fimmu.2022.961805 PMID: 36304470
  46. Shuel, S.L. Targeted cancer therapies. Can. Fam. Physician, 2022, 68(7), 515-518. doi: 10.46747/cfp.6807515 PMID: 35831091
  47. Marshall, A.C. Traditional Chinese medicine and clinical pharmacology; Springer International Publishing, 2020.
  48. Jemal, A.; Center, M.M.; DeSantis, C.; Ward, E.M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev., 2010, 19(8), 1893-1907. doi: 10.1158/1055-9965.EPI-10-0437 PMID: 20647400
  49. Sultan, D.H.; Ghebrezadik, D.G.; Smith, D.S.; Ombengi, D.N.; Ayedun, L.; Luke, F.E.; Demery, J.L.; Scoggins, C.T.; Penn-Marshall, M. A problem in NIH and federally funded prostate cancer interventional clinical trials. J. Racial Ethn. Health Disparities, 2023, 2023, 1-6. doi: 10.1007/s40615-023-01737-9 PMID: 37552424
  50. Kaypee, S.; Singh, S.; Swarnkar, S.; Kundu, TK. Emerging epigenetic therapies—lysine acetyltransferase inhibitors. In: Epigenetic Cancer Therapy; Academic Press, 2023. pp. 459-505.
  51. Sheena, B.S.; Hiebert, L.; Han, H.; Ippolito, H.; Abbasi-Kangevari, M.; Abbasi-Kangevari, Z.; Abbastabar, H.; Abdoli, A.; Abubaker Ali, H.; Adane, M.M.; Adegboye, O.A.; Adnani, Q.E.S.; Advani, S.M.; Afzal, M.S.; Afzal, S.; Aghaie Meybodi, M.; Ahadinezhad, B.; Ahinkorah, B.O.; Ahmad, S.; Ahmad, T.; Ahmadi, S.; Ahmed, H.; Ahmed, M.B.; Ahmed Rashid, T.; Akalu, G.T.; Aklilu, A.; Akram, T.; Al Hamad, H.; Alahdab, F.; Alem, A.Z.; Alem, D.T.; Alhalaiqa, F.A.N.; Alhassan, R.K.; Ali, L.; Ali, M.A.; Alimohamadi, Y.; Alipour, V.; Alkhayyat, M.; Almustanyir, S.; Al-Raddadi, R.M.; Altawalah, H.; Amini, S.; Amu, H.; Ancuceanu, R.; Andrei, C.L.; Andrei, T.; Anoushiravani, A.; Ansar, A.; Anyasodor, A.E.; Arabloo, J.; Arab-Zozani, M.; Argaw, A.M.; Argaw, Z.G.; Arshad, M.; Artamonov, A.A.; Ashraf, T.; Atlaw, D.; Ausloos, F.; Ausloos, M.; Azadnajafabad, S.; Azangou-Khyavy, M.; Azari Jafari, A.; Azarian, G.; Bagheri, S.; Bahadory, S.; Baig, A.A.; Banach, M.; Barati, N.; Barrow, A.; Batiha, A-M.M.; Bejarano Ramirez, D.F.; Belgaumi, U.I.; Berhie, A.Y.; Bhagat, D.S.; Bhardwaj, N.; Bhardwaj, P.; Bhattacharyya, K.; Bhojaraja, V.S.; Bijani, A.; Biondi, A.; Bodicha, B.B.A.; Bojia, H.A.; Boloor, A.; Bosetti, C.; Braithwaite, D.; Briko, N.I.; Butt, Z.A.; Cámera, L.A.; Chakinala, R.C.; Chakraborty, P.A.; Charan, J.; Chen, S.; Choi, J-Y.J.; Choudhari, S.G.; Chowdhury, F.R.; Chu, D-T.; Chung, S-C.; Cortesi, P.A.; Cowie, B.C.; Culbreth, G.T.; Dadras, O.; Dai, X.; Dandona, L.; Dandona, R.; De la Hoz, F.P.; Debela, S.A.; Dedefo, M.G.; Demeke, F.M.; Demie, T.G.G.; Demissie, G.D.; Derbew Molla, M.; Desta, A.A.; Dhamnetiya, D.; Dhimal, M.L.; Dhimal, M.; Didehdar, M.; Doan, L.P.; Dorostkar, F.; Drake, T.M.; Eghbalian, F.; Ekholuenetale, M.; El Sayed, I.; El Sayed Zaki, M.; Elhadi, M.; Elmonem, M.A.; Elsharkawy, A.; Enany, S.; Enyew, D.B.; Erkhembayar, R.; Eskandarieh, S.; Esmaeilzadeh, F.; Ezzikouri, S.; Farrokhpour, H.; Fetensa, G.; Fischer, F.; Foroutan, M.; Gad, M.M.; Gaidhane, A.M.; Gaidhane, S.; Galles, N.C.; Gallus, S.; Gebremeskel, T.G.; Gebreyohannes, E.A.; Ghadiri, K.; Ghaffari, K.; Ghafourifard, M.; Ghamari, S-H.; Ghashghaee, A.; Gholami, A.; Gholizadeh, A.; Gilani, A.; Goel, A.; Golechha, M.; Goleij, P.; Golinelli, D.; Gorini, G.; Goshu, Y.A.; Griswold, M.G.; Gubari, M.I.M.; Gupta, B.; Gupta, S.; Gupta, V.B.; Gupta, V.K.; Haddadi, R.; Halwani, R.; Hamid, S.S.; Hamidi, S.; Hanif, A.; Haque, S.; Harapan, H.; Hargono, A.; Hariri, S.; Hasaballah, A.I.; Hasan, S.M.M.; Hassanipour, S.; Hassankhani, H.; Hay, S.I.; Hayat, K.; Heidari, G.; Herteliu, C.; Heyi, D.Z.; Hezam, K.; Holla, R.; Hosseini, M-S.; Hosseini, M.; Hosseinzadeh, M.; Hostiuc, M.; Househ, M.; Huang, J.; Hussein, N.R.; Iavicoli, I.; Ibitoye, S.E.; Ilesanmi, O.S.; Ilic, I.M.; Ilic, M.D.; Irham, L.M.; Islam, J.Y.; Ismail, N.E.; Jacobsen, K.H.; Jadidi-Niaragh, F.; Javadi Mamaghani, A.; Jayaram, S.; Jayawardena, R.; Jebai, R.; Jha, R.P.; Joseph, N.; Joukar, F.; Kaambwa, B.; Kabir, A.; Kabir, Z.; Kalhor, R.; Kandel, H.; Kanko, T.K.T.; Kantar, R.S.; Karaye, I.M.; Kassa, B.G.; Kemp Bohan, P.M.; Keykhaei, M.; Khader, Y.S.; Khajuria, H.; Khan, G.; Khan, I.A.; Khan, J.; Khan, M.A.B.; Khanali, J.; Khater, A.M.; Khatib, M.N.; Khodadost, M.; Khoja, A.T.; Khosravizadeh, O.; Khubchandani, J.; Kim, G.R.; Kim, H.; Kim, M.S.; Kim, Y.J.; Kocarnik, J.M.; Kolahi, A-A.; Koteeswaran, R.; Kumar, G.A.; La Vecchia, C.; Lal, D.K.; Landires, I.; Lasrado, S.; Lazarus, J.V.; Ledda, C.; Lee, D.W.; Lee, S.; Lee, Y.Y.; Levi, M.; Li, J.; Lim, S.S.; Lobo, S.W.; Lopukhov, P.D.; Loureiro, J.A.; MacLachlan, J.H.; Magdy Abd El Razek, H.; Magdy Abd El Razek, M.; Majeed, A.; Makki, A.; Malekpour, M-R.; Malekzadeh, R.; Malik, A.A.; Mansour-Ghanaei, F.; Mansournia, M.A.; Martins-Melo, F.R.; Matthews, P.C.; Mendoza, W.; Menezes, R.G.; Meretoja, T.J.; Mersha, A.G.; Mestrovic, T.; Miller, T.R.; Minh, L.H.N.; Mirica, A.; Mirmoeeni, S.; Mirrakhimov, E.M.; Misra, S.; Mithra, P.; Moazen, B.; Mohamadkhani, A.; Mohammadi, M.; Mohammed, S.; Moka, N.; Mokdad, A.H.; Moludi, J.; Momtazmanesh, S.; Monasta, L.; Moradi, G.; Moradzadeh, M.; Moradzadeh, R.; Moraga, P.; Mostafavi, E.; Mubarik, S.; Muniyandi, M.; Murray, C.J.L.; Naghavi, M.; Naimzada, M.D.; Narasimha Swamy, S.; Natto, Z.S.; Nayak, B.P.; Nazari, J.; Negoi, I.; Negru, S.M.; Nejadghaderi, S.A.; Neupane Kandel, S.; Nguyen, H.L.T.; Ngwa, C.H.; Niazi, R.K.; Nnaji, C.A.; Noubiap, J.J.; Nowroozi, A.; Nuñez-Samudio, V.; Oancea, B.; Ochir, C.; Odukoya, O.O.; Oh, I-H.; Olagunju, A.T.; Olakunde, B.O.; Omar Bali, A.; Omer, E.; Otstavnov, S.S.; Oumer, B.; Padubidri, J.R.; Pana, A.; Pandey, A.; Park, E-C.; Pashazadeh Kan, F.; Patel, U.K.; Paudel, U.; Petcu, I-R.; Piracha, Z.Z.; Pollok, R.C.G.; Postma, M.J.; Pourshams, A.; Poustchi, H.; Rabiee, M.; Rabiee, N.; Rafiei, A.; Rafiei, S.; Raghuram, P.M.; Rahman, M.; Rahmani, A.M.; Rahmawaty, S.; Rajesh, A.; Ranasinghe, P.; Rao, C.R.; Rao, S.J.; Rashidi, M.; Rashidi, M-M.; Rawaf, D.L.; Rawaf, S.; Rawassizadeh, R.; Rezaei, N.; Rezapour, A.; Rezazadeh-Khadem, S.; Rodriguez, J.A.B.; Rwegerera, G.M.; Sabour, S.; Saddik, B.; Saeb, M.R.; Saeed, U.; Sahebkar, A.; Saif-Ur-Rahman, K.M.; Salahi, S.; Salimzadeh, H.; Sampath, C.; Samy, A.M.; Sanabria, J.; Sanmarchi, F.; Santric-Milicevic, M.M.; Sarveazad, A.; Sathian, B.; Sawhney, M.; Seidu, A-A.; Sepanlou, S.G.; Seylani, A.; Shahabi, S.; Shaikh, M.A.; Shaker, E.; Shakhmardanov, M.Z.; Shannawaz, M.; Shenoy, S.M.; Shetty, J.K.; Shetty, P.H.; Shibuya, K.; Shin, J.I.; Shobeiri, P.; Sibhat, M.M.; Singh, A.D.; Singh, J.A.; Singh, S.; Skryabin, V.Y.; Skryabina, A.A.; Sohrabpour, A.A.; Song, S.; Tabaeian, S.P.; Tadesse, E.G.; Taheri, M.; Tampa, M.; Tan, K-K.; Tavakoli, A.; Tbakhi, A.; Tefera, B.N.; Tehrani-Banihashemi, A.; Tesfaw, H.M.; Thapar, R.; Thavamani, A.; Tohidast, S.A.; Tollosa, D.N.; Tosti, M.E.; Tovani-Palone, M.R.; Traini, E.; Tran, M.T.N.; Trihandini, I.; Tusa, B.S.; Ullah, I.; Vacante, M.; Valadan Tahbaz, S.; Valdez, P.R.; Varthya, S.B.; Vo, B.; Waheed, Y.; Weldesenbet, A.B.; Woldemariam, M.; Xu, S.; Yahyazadeh Jabbari, S.H.; Yaseri, M.; Yeshaw, Y.; Yiğit, V.; Yirdaw, B.W.; Yonemoto, N.; Yu, C.; Yunusa, I.; Zahir, M.; Zaki, L.; Zamani, M.; Zamanian, M.; Zastrozhin, M.S.; Vos, T.; Ward, J.W.; Dirac, M.A. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol. Hepatol., 2022, 7(9), 796-829. doi: 10.1016/S2468-1253(22)00124-8 PMID: 35738290
  52. Morgan, E.; Arnold, M.; Gini, A.; Lorenzoni, V.; Cabasag, C.J.; Laversanne, M.; Vignat, J.; Ferlay, J.; Murphy, N.; Bray, F. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut, 2023, 72(2), 338-344. doi: 10.1136/gutjnl-2022-327736 PMID: 36604116
  53. Kulshrestha, S.; Goel, A.; Siddiqi, N.J.; Fatima, S.; Sharma, B. Cancer-Preventive Activity of Argemone mexicana Linn Leaves and Its Effect on TNF-α and NF-κB Signalling. Cancers (Basel), 2023, 15(23), 5654. doi: 10.3390/cancers15235654 PMID: 38067358
  54. Singh, R.; Sharma, P.; Singh, M.; Arora, S.K. The evaluation of in vitro toxicity of the protein (LL 4218) isolated from leaves of Argemone mexicana in human hepatoma-derived cell line (HepG2) using multiplexing approach. J. Nat. Pharmaceut., 2011, 2(4), 179. doi: 10.4103/2229-5119.92854
  55. Verma, S.K.; Singh, S.K.; Abhishek, M.; Shivsharan, S. In vitro cytotoxicity of Argemone mexicana against different human cancer cell lines. Int. J. Chem. Environ. Pharm. Res., 2010, 1(1), 37-39.
  56. Borlak, J.; Chougule, A.; Singh, P.K. How useful are clinical liver function tests in in vitro human hepatotoxicity assays? Toxicol. In Vitro, 2014, 28(5), 784-795. doi: 10.1016/j.tiv.2014.03.006 PMID: 24685772
  57. Alam, A.; Khan, A.A. Argemone mexicana L.: A weed with versatile medicinal and pharmacological applications. Ann. Phytomed., 2020, 9(1), 218-223. doi: 10.21276/ap.2020.9.1.29
  58. Tathe, P.G.; Deshmukh, A.S. A review on role of Indian medicinal plants in treatment of Icterus. Int. J. Sci. Res. Arch., 2023, 8(2), 445-456. doi: 10.30574/ijsra.2023.8.2.0278
  59. Waghmare, K.; Ghayal, N.; Shindikar, M.; Jadhav, R. Evaluation of efficacy of phytochemicals from invasive weeds against Dolichos bean Aphid, Aphis craccivora Koch. Int. J. Ecol. Environ. Sci., 2023, 49(6), 519-524. doi: 10.55863/ijees.2023.2892
  60. Matada, B.S.; Pattanashettar, R.; Yernale, N.G. A comprehensive review on the biological interest of quinoline and its derivatives. Bioorg. Med. Chem., 2021, 32, 115973. doi: 10.1016/j.bmc.2020.115973 PMID: 33444846
  61. Neag, M.A.; Mocan, A.; Echeverría, J.; Pop, R.M.; Bocsan, C.I.; Crişan, G.; Buzoianu, A.D. Berberine: Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front. Pharmacol., 2018, 9, 557. doi: 10.3389/fphar.2018.00557 PMID: 30186157
  62. Dash, G.K.; Murthy, P.N. Evaluation of Argemone mexicana Linn. Leaves for wound healing activity. J. Nat. Prod. Plant Resour., 2011, 1(1), 46-56.
  63. ji, G.; Shukla, S.K.; Dwivedi, P.; Sundaram, S.; Prakash, R. Inhibitive effect of Argemone mexicana plant extract on acid corrosion of mild steel. Ind. Eng. Chem. Res., 2011, 50(21), 11954-11959. doi: 10.1021/ie201450d
  64. Bhat, S.H.; Shrivastava, R.; Malla, M.Y.; Iqbal, M.; Anjum, T.; Mir, A.H.; Sharma, M. Hepatoprotective activity of Argemone mexicana Linn against toxic effects of carbon tetrachloride in rats. World J. Pharm. Res., 2014, 3(3), 4037-4048.
  65. Adam, S.I.; Idris, I.A.; Abdelgadir, E.H.; Ahmed, R.H.; Kamal, E.E. Evaluation of the hepatoprotective activity of Argemone mexicana aerial Part Extracts on CCL_4 induced liver damage in wistar rats. Br. J. Pharmacol. Toxicol., 2011, 2(5), 251-256.
  66. Malik, C.; Mohanty, J.P.; Pradhan, S.; Sharma, C. Phytochemistry and pharmacology of Argemone mexicana Linn-An Indian medicinal plant. Res. J. Pharmacogn. Phytochem., 2023, 15, 27-32.
  67. Gali, K.; Ramakrishnan, G.; Kothai, R.; Jaykar, B. In-vitro anti-cancer activity of methanolic extract of leaves of Argemone mexicana Linn. Int. J. Pharm. Tech. Res., 2011, 3, 1329-1333.
  68. Sakthivadivel, M.; Thilagavathy, D. Larvicidal and chemosterilant activity of the acetone fraction of petroleum ether extract from Argemone mexicana L. seed. Bioresour. Technol., 2003, 89(2), 213-216. doi: 10.1016/S0960-8524(03)00038-5 PMID: 12699943
  69. Leyva-Peralta, M.A.; Robles-Zepeda, R.E.; Garibay-Escobar, A.; Ruiz-Bustos, E.; Alvarez-Berber, L.P.; Gálvez-Ruiz, J.C. In vitro anti-proliferative activity of Argemone gracilenta and identification of some active components. BMC Complement. Altern. Med., 2015, 15(1), 13. doi: 10.1186/s12906-015-0532-8 PMID: 25652581
  70. Miriam, J.; Srimathi, R.; Jayaraman, G. In vitro and in vivo studies of Argemone mexicana linn. extracts against cobra venom (Naja naja) induced toxicity. Curr. Trend Biotechnol. Pharm., 2022, 16(S1), 1-8.
  71. Mengie, A.T.; Chekol, A.E.; Tilahun, M.Z.; Mekonnen, A.M.; Shumet, Y.Y.; Tesfaw, Addis, G.; Dagnaw, Baye, N.; Bogale, K.A.; Adela, A.M.; Gobezie, Y.T.; Ayalew, T.G.; Berihun, D.S. Evaluation of in vivo wound-healing and anti-inflammatory activities of solvent fractions of fruits of Argemone mexicana L. (Papaveraceae). Evid. Based Complement. Alternat. Med., 2022, 2022, 1-17. doi: 10.1155/2022/6154560 PMID: 36457593
  72. Al-Tohamy, R.; Ali, S.S.; Saad-Allah, K.; Fareed, M.; Ali, A.; El-Badry, A.; El-Zawawy, N.A.; Wu, J.; Sun, J.; Mao, G.H.; Rupani, P.F. Phytochemical analysis and assessment of antioxidant and antimicrobial activities of some medicinal plant species from Egyptian flora. J. Appl. Biomed., 2018, 16(4), 289-300. doi: 10.1016/j.jab.2018.08.001
  73. Prabhakaran, D.; Milisevi, Mm.; Rajeshka NNA, A. Anticancer activity of Argemone mexicana L.(flowers) against human liver cancer (HEPG2) cell line. Asian J. Pharm. Clin. Res., 2017, 10(10), 351-353. doi: 10.22159/ajpcr.2017.v10i10.20744
  74. Datkhile, K.D.; Patil, S.R.; Patil, M.N.; Durgawale, P.P.; Jagdale, N.J.; Deshmukh, V.N. Studies on phytoconstituents, in vitro antioxidant, antibacterial and cytotoxicity potential of Argemone mexicana Linn. (family: Papaveraceae). J. Nat. Sci. Biol. Med., 2020, 11, 198-205.
  75. Soto, K.M.; Pérez Bueno, J.J.; Mendoza López, M.L.; Apátiga-Castro, M.; López-Romero, J.M.; Mendoza, S.; Manzano-Ramírez, A. Antioxidants in traditional mexican medicine and their applications as antitumor treatments. Pharmaceuticals, 2023, 16(4), 482. doi: 10.3390/ph16040482 PMID: 37111239
  76. Liu, C.; Yang, S.; Wang, K.; Bao, X.; Liu, Y.; Zhou, S.; Liu, H.; Qiu, Y.; Wang, T.; Yu, H. Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma. Biomed. Pharmacother., 2019, 120, 109543. doi: 10.1016/j.biopha.2019.109543 PMID: 31655311
  77. Juaid, N.; Amin, A.; Abdalla, A.; Reese, K.; Alamri, Z.; Moulay, M.; Abdu, S.; Miled, N. Anti-hepatocellular carcinoma biomolecules: molecular targets insights. Int. J. Mol. Sci., 2021, 22(19), 10774. doi: 10.3390/ijms221910774 PMID: 34639131
  78. Du, Q.; Meng, X.; Wang, S. A comprehensive review on the chemical properties, plant sources, pharmacological activities, pharmacokinetic and toxicological characteristics of tetrahydropalmatine. Front. Pharmacol., 2022, 13, 890078. doi: 10.3389/fphar.2022.890078 PMID: 35559252
  79. Rui, Y.; Li, S.; Luan, F.; Li, D.; Liu, R.; Zeng, N. Several alkaloids in Chinese herbal medicine protect acute kidney injury: focus on mechanism and target analysis. Oxid. Med. Cell. Longev., 2022, 2022, 1-16. doi: 10.1155/2022/2427802 PMID: 35602100
  80. Yoo, E.S.; Choo, G.S.; Kim, S.H.; Woo, J.S.; Kim, H.J.; Park, Y.S.; Kim, B.S.; Kim, S.K.; Park, B.K.; Cho, S.D.; Nam, J.S.; Choi, C.S.; Che, J.H.; Jung, J.Y. Antitumor and apoptosis-inducing effects of piperine on human melanoma cells. Anticancer Res., 2019, 39(4), 1883-1892. doi: 10.21873/anticanres.13296 PMID: 30952729
  81. N, B.; Chandrashekar, K.R.; Prabhu, A.; Rekha, P.D. Tetrandrine isolated from Cyclea peltata induces cytotoxicity and apoptosis through ROS and caspase pathways in breast and pancreatic cancer cells. In Vitro Cell. Dev. Biol. Anim., 2019, 55(5), 331-340. doi: 10.1007/s11626-019-00332-9 PMID: 30945115
  82. Zhang, Y.; Goto, M.; Oda, A.; Hsu, P.L.; Guo, L.L.; Fu, Y.H.; Morris-Natschke, S.L.; Hamel, E.; Lee, K.H.; Hao, X.J. Antiproliferative aspidosperma-type monoterpenoid indole alkaloids from Bousigonia mekongensis inhibit tubulin polymerization. Molecules, 2019, 24(7), 1256. doi: 10.3390/molecules24071256 PMID: 30935100
  83. Wang, Y.; Zhang, S.; Liu, J.; Fang, B.; Yao, J.; Cheng, B. Matrine inhibits the invasive and migratory properties of human hepatocellular carcinoma by regulating epithelial‑mesenchymal transition. Mol. Med. Rep., 2018, 18(1), 911-919. doi: 10.3892/mmr.2018.9023 PMID: 29845189
  84. Zhou, N.; Li, J.; Li, T.; Chen, G.; Zhang, Z.; Si, Z. Matrine-induced apoptosis in Hep3B cells via the inhibition of MDM2. Mol. Med. Rep., 2017, 15(1), 442-450. doi: 10.3892/mmr.2016.5999 PMID: 27959389
  85. Wang, X.; Feng, Y.; Wang, N.; Cheung, F.; Tan, H.Y.; Zhong, S.; Li, C.; Kobayashi, S. Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy. BioMed Res. Int., 2014, 2014, 1-14. doi: 10.1155/2014/530342 PMID: 25379508
  86. Li, M.; Zhang, M.; Zhang, Z.; Liu, N.; Han, X.; Liu, Q.; Deng, W.; Liao, C. Induction of apoptosis by berberine in hepatocellular carcinoma HepG2 cells via downregulation of NF-κB. Oncol. Res., 2017, 25(2), 233-239. doi: 10.3727/096504016X14742891049073 PMID: 28277195
  87. Li, J.; Li, O.; Kan, M.; Zhang, M.; Shao, D.; Pan, Y.; Zheng, H.; Zhang, X.; Chen, L.; Liu, S. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma. Mol. Med. Rep., 2015, 12(3), 4572-4577. doi: 10.3892/mmr.2015.3926 PMID: 26081696
  88. Zhang, P.; Wang, Q.; Lin, Z.; Yang, P.; Dou, K.; Zhang, R. Berberine inhibits growth of liver cancer cells by suppressing glutamine uptake. OncoTargets Ther., 2020, 12, 11751-11763. doi: 10.2147/OTT.S235667 PMID: 32021249
  89. Rauf, A.; Abu-Izneid, T.; Khalil, A.A.; Imran, M.; Shah, Z.A.; Emran, T.B.; Mitra, S.; Khan, Z.; Alhumaydhi, F.A.; Aljohani, A.S.M.; Khan, I.; Rahman, M.M.; Jeandet, P.; Gondal, T.A. Berberine as a potential anticancer agent: A comprehensive review. Molecules, 2021, 26(23), 7368. doi: 10.3390/molecules26237368 PMID: 34885950
  90. Du, D.; Liu, C.; Qin, M.; Zhang, X.; Xi, T.; Yuan, S.; Hao, H.; Xiong, J. Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma. Acta Pharm. Sin. B, 2022, 12(2), 558-580. doi: 10.1016/j.apsb.2021.09.019 PMID: 35256934
  91. Almatroodi, S.A.; Alsahli, M.A.; Rahmani, A.H. Berberine: An important emphasis on its anticancer effects through modulation of various cell signaling pathways. Molecules, 2022, 27(18), 5889. doi: 10.3390/molecules27185889 PMID: 36144625
  92. Al-Maharik, N. Isolation of naturally occurring novel isoflavonoids: an update. Nat. Prod. Rep., 2019, 36(8), 1156-1195. doi: 10.1039/C8NP00069G PMID: 30632588
  93. Singh, S.; Verma, M.; Malhotra, M.; Prakash, S.; Singh, T.D. Cytotoxicity of alkaloids isolated from Argemone mexicana on SW480 human colon cancer cell line. Pharm. Biol., 2016, 54(4), 740-745. doi: 10.3109/13880209.2015.1073334 PMID: 26439487
  94. Uddin, M.S.; Hossain, M.F.; Mamun, A.A.; Shah, M.A.; Hasana, S.; Bulbul, I.J.; Sarwar, M.S.; Mansouri, R.A.; Ashraf, G.M.; Rauf, A.; Abdel-Daim, M.M.; Bin-Jumah, M.N. Exploring the multimodal role of phytochemicals in the modulation of cellular signaling pathways to combat age-related neurodegeneration. Sci. Total Environ., 2020, 725, 138313. doi: 10.1016/j.scitotenv.2020.138313 PMID: 32464743
  95. Ouédraogo, J.C.W.; Dicko, C.; Kini, F.B.; Bonzi-Coulibaly, Y.L.; Dey, E.S. Enhanced extraction of flavonoids from Odontonema strictum leaves with antioxidant activity using supercritical carbon dioxide fluid combined with ethanol. J. Supercrit. Fluids, 2018, 131, 66-71. doi: 10.1016/j.supflu.2017.08.017
  96. Zakaria, K.N.; Amid, A.; Zakaria, Z.; Jamal, P.; Ismail, A. Anti-proliferative activity of triterpenes isolated from Clinicanthus nutans on Hep-G2 liver cancer cells. Asian Pac. J. Cancer Prev., 2019, 20(2), 563-567. doi: 10.31557/APJCP.2019.20.2.563 PMID: 30803221
  97. Kim, G.H.; Kan, S.Y.; Kang, H.; Lee, S.; Ko, H.M.; Kim, J.H.; Lim, J.H. Ursolic acid suppresses cholesterol biosynthesis and exerts anti-cancer effects in hepatocellular carcinoma cells. Int. J. Mol. Sci., 2019, 20(19), 4767. doi: 10.3390/ijms20194767 PMID: 31561416
  98. Dubey, NK.; Dwivedy, AK.; Chaudhari, AK.; Das, S. Common toxic plants and their forensic significance. In: Natural Products and Drug Discovery; Elsevier, 2018. pp. 349-374.
  99. Nyirenda, K.K. Toxicity potential of cyanogenic glycosides in edible plants. Med. Toxicol., 2020, 2020, 1-9.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Bentham Science Publishers, 2025